Superworth

Healthequity profit margin HQY

Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.

Net margin, 12 months
17.4%
Operating margin, 12 months
25.8%
Net margin on a year earlier
+5.9 pts
Peer median
11.6%

Over the twelve months to Jul 31, 2026, Healthequity kept 17.4% of its revenue as net profit, with an operating margin of 25.8% and a gross margin of 71.2%.

Five years earlier its net margin was 0.1%.

The median for 10 credit services stocks of a similar size is 11.6%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY202616.4%24.6%69.5%
FY20258.1%13.5%64.8%
FY20245.6%11.8%62.3%
FY2023−3.0%1.1%57.1%
FY2022−5.9%−3.2%56.1%
FY20211.2%4.6%56.6%
FY20207.5%14.5%61.3%
FY201925.7%27.0%63.1%
FY201820.6%23.7%58.8%
FY201714.8%23.1%59.6%
FY201613.1%20.6%57.3%
FY201511.6%19.2%54.6%
FY20142.0%18.6%52.9%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY2717.4%+5.9 pts25.8%
Q1 FY2717.3%+7.5 pts25.6%
Q4 FY2616.4%+8.3 pts24.6%
Q3 FY2614.9%+6.5 pts22.7%
Q2 FY2611.5%+1.9 pts18.5%
Q1 FY269.8%+2.1 pts16.4%
Q4 FY258.1%+2.5 pts13.5%
Q3 FY258.4%+5.4 pts13.8%
Q2 FY259.6%+8.2 pts15.5%
Q1 FY257.7%+8.6 pts13.1%
Q4 FY245.6%+8.6 pts11.8%
Q3 FY243.0%+10.1 pts9.5%

Against its peers

Companies in Financial - Credit Services nearest Healthequity's size, closest first, today.

CompanyProfit margin
HQYHealthequity17.4%
ETSYEtsy7.3%
ZGZillow2.0%
WEXWEX12.6%
EXLSExlService11.2%
OMFOneMain15.4%
CARTMaplebear12.0%
CACCCredit Acceptance21.5%
CSGPCostar2.1%
AMTMAmentum1.4%
RELYRemitly Global16.9%
Peer median11.6%

Where Healthequity ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Healthequity

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.